Metraipolis › archive › dc_4393b90428ea

Clinical Outcomes of Sonidegib in Vismodegib-Exposed Locally Advanced Basal Cell Carcinoma: Insights From a Multicenter Descriptive Study — Europe PMC PMID:41657480

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41657480
DOI
10.1155/jskc/9016298
License (as archived)
solo-consultazione
Archived
2026-11-06T02:06:50.867Z
SHA-256 of the archived text
499df9b6c5edc7f167bbae89a441ada86d9f02d7a3d1f4709da9319a005441fa
Stable URL of this page
https://metraipolis.com/documento/dc_4393b90428ea

How to cite

Clinical Outcomes of Sonidegib in Vismodegib-Exposed Locally Advanced Basal Cell Carcinoma: Insights From a Multicenter Descriptive Study — Europe PMC PMID:41657480 — Europe PMC (en), https://europepmc.org/article/MED/41657480 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4393b90428ea (Metraipolis archive dc_4393b90428ea, sha256 499df9b6c5edc7f167bbae89a441ada86d9f02d7a3d1f4709da9319a005441fa)
BibTeX
@misc{dc4393b90428ea,
  title = {Clinical Outcomes of Sonidegib in Vismodegib-Exposed Locally Advanced Basal Cell Carcinoma: Insights From a Multicenter Descriptive Study — Europe PMC PMID:41657480},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41657480},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4393b90428ea; sha256 499df9b6c5edc7f167bbae89a441ada86d9f02d7a3d1f4709da9319a005441fa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41657480. Agents can read the archived copy with the MCP tool read_document.